Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Non-Small Cell Lung Cancer
Trial Locations (11)

Unknown

Research Site, Amsterdam

Research Site, Apeldoorn

Research Site, Groningen

Research Site, Helmond

Research Site, Hengelo

Research Site, Hoofddorp

Research Site, Leiden

Research Site, The Hague

Research Site, Veldhoven

Research Site, Venlo

Research Site, Zutphen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY